Interleukin 1 binding to its type i, but not type ii receptor, modulates the in vivo acute phase response

30Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neutralizing monoclonal antibodies against the murine interleukin 1 (IL-1) type I (mAb 35F5) and type II receptor (mAb 4E2) were used to passively immunize mice prior to exogenous murine IL-1α administration or a sterile-turpentine induced abscess. When mice were passively immunized with 35F5, the anorexia, weight loss and increased plasma acute phase protein levels in response to exogenous IL-1α administration or a turpentine abscess were significantly attenuated. In contrast, passive immunization with 4E2 had only variable effects on food intake, body weight and the hepatic acute phase response in mice administered IL-1α. In mice following a turpentine abscess, type II receptor blockade (4E2) either had no effect, or in some cases, actually increased the plasma IL-6 and acute phase protein responses. We conclude that in response to a turpentine abscess, the anorexia, weight loss and the induction of several hepatic acute phase reactants result in part from IL-1 binding to its type I receptor. Binding of IL-1 to the type II IL-1 receptor does not appear to be involved in the induction of these host nonspecific responses to inflammation. © 1995 Academic Press, Inc.

Cite

CITATION STYLE

APA

Oldenburg, H. S. A., Pruitt, J. H., Lazarus, D. D., Rogy, M. A., Chizzonite, R., Lowry, S. F., & Moldawer, L. L. (1995). Interleukin 1 binding to its type i, but not type ii receptor, modulates the in vivo acute phase response. Cytokine, 7(6), 510–516. https://doi.org/10.1006/cyto.1995.0069

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free